CEP-751 inhibits trk receptor tyrosine kinase activityin vitro and exhibits anti-tumor activity by Camoratto, Anna Marie, Jani, Jitesh P., Angeles, Thelma S., Maroney, Anna C., Sanders, Christa Y., Murakata, Chikara, Neff, Nicola T., Vaught, Jeffry L., Isaacs, John T., Dionne, Craig A.

Get full text

CEP‐751 inhibits trk receptor tyrosine kinase activity in vitro and exhibits anti‐tumor activity by Camoratto, Anna Marie, Jani, Jitesh P., Angeles, Thelma S., Maroney, Anna C., Sanders, Christa Y., Murakata, Chikara, Neff, Nicola T., Vaught, Jeffry L., Isaacs, John T., Dionne, Craig A.

Get full text

mTORC1 Inhibition Protects Human Regulatory T Cells From Granzyme-B-Induced Apoptosis by Eskandari, Siawosh K., Allos, Hazim, Al Dulaijan, Basmah S., Melhem, Gandolina, Sulkaj, Ina, Alhaddad, Juliano B., Saad, Anis J., Deban, Christa, Chu, Philip, Choi, John Y., Kollar, Branislav, Pomahac, Bohdan, Riella, Leonardo V., Berger, Stefan P., Sanders, Jan S. F., Lieberman, Judy, Li, Li, Azzi, Jamil R.

Get full text

Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci by Sanders, Stephan J., He, Xin, Willsey, A. Jeremy, Ercan-Sencicek, A. Gulhan, Samocha, Kaitlin E., Cicek, A. Ercument, Murtha, Michael T., Bal, Vanessa H., Bishop, Somer L., Dong, Shan, Goldberg, Arthur P., Jinlu, Cai, Keaney, John F., Klei, Lambertus, Mandell, Jeffrey D., Moreno-De-Luca, Daniel, Poultney, Christopher S., Robinson, Elise B., Smith, Louw, Solli-Nowlan, Tor, Su, Mack Y., Teran, Nicole A., Walker, Michael F., Werling, Donna M., Beaudet, Arthur L., Cantor, Rita M., Fombonne, Eric, Geschwind, Daniel H., Grice, Dorothy E., Lord, Catherine, Lowe, Jennifer K., Mane, Shrikant M., Martin, Donna M., Morrow, Eric M., Talkowski, Michael E., Sutcliffe, James S., Walsh, Christopher A., Yu, Timothy W., Ledbetter, David H., Martin, Christa Lese, Cook, Edwin H., Buxbaum, Joseph D., Daly, Mark J., Devlin, Bernie, Roeder, Kathryn, State, Matthew W.

Get full text